Trial – AMGEN/IQVIA
Suffering from Chronic Hives?
A 32-week Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging, Phase 2b Study to Evaluate Efficacy and Safety of xxxxxxxxxx for the Treatment of Chronic Spontaneous Urticaria
Males and Females between the ages of 18-80 may qualify.
To participate in your local study, please contact (949) 844-0442 or fill out the form below.
Protocol # 20190194
Share this post
Subscribe To Our Newsletter
Get updates and learn from the best
More To Explore
Call us, write us, or knock on our door.
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.
- 27020 Alicia Parkway , Suite G Laguna Niguel, CA 92677
- Monday - Friday: 8AM - 5PM
- Saturday and Sunday: Closed
- (949) 707-5734
- info@avancetrials.com